Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility

Neurology

Volumn 89, Issue 13, 2017, Pages 1330-1337

  Langer Gould, Annette ^a,b   Wu, Jun ^a   Lucas, Robyn ^c   Smith, Jessica ^a   Gonzales, Edlin ^a   Amezcua, Lilyana ^d   Haraszti, Samantha ^a,g   Chen, Lie Hong ^a   Quach, Hong ^e   James, Judith A ^f   Barcellos, Lisa F ^e   Xiang, Anny H ^a  

^a KAISER PERMANENTE   (United States)

^b Southern California Permanente Medical Group   (United States)

^c The Australian National University   (Australia)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^g PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; EARLY ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; VIRUS CAPSID ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; HLA-DRB1*15 ANTIGEN; VIRUS ANTIBODY;

ADULT; AGE; ARTICLE; BLACK PERSON; BREAST FEEDING; CAUCASIAN; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; EDUCATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ETHNIC GROUP; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISPANIC; HUMAN; HYGIENE HYPOTHESIS; LOW INCOME COUNTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE INCOME COUNTRY; MONONUCLEOSIS; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SEX; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOCIAL STATUS; SOCIOECONOMICS; BLOOD; CALIFORNIA; ETHNOLOGY; GENETICS; HYGIENE; INCIDENCE; MIGRANT; STATISTICAL MODEL; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; BREAST FEEDING; CALIFORNIA; CYTOMEGALOVIRUS; EMIGRANTS AND IMMIGRANTS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; HLA-DRB1 CHAINS; HUMANS; HYGIENE; INCIDENCE; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 85030612587     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000004412     Document Type: Article

References (32)

1. Almohmeed YH, Avenell A, Aucott L, Vickers MA. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis. PLoS One 2013;8:e61110.
2. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015;14:263-273.
3. Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007;64:72-75.
4. Pakpoor J, Disanto G, Gerber JE, et al. The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler 2013;19:162-166.
5. Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 2001;286:3083-3088.
6. Lucas RM, Ponsonby AL, Dear K, et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011;77:371-379.
7. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006;63:839-844.
8. Sundstrom P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004;62:2277-2282.
9. Ponsonby AL, van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA 2005;293:463-469.
10. Waubant E, Mowry EM, Krupp L, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology 2011;76:1989-1995.
11. Sundqvist E, Bergstrom T, Daialhosein H, et al. Cytomeg-alovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler 2014;20:165-173.
12. Pakpoor J, Pakpoor J, Disanto G, Giovannoni G, Ramagopalan SV. Cytomegalovirus and multiple sclerosis risk. J Neurol 2013;260:1658-1660.
13. Cherry JD, Harrison GJ, Kaplan SL, Hotez PJ, Steinbach WJ. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia: Saunders/Elsevier; 2014.
14. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006;43:1143-1151.
15. Hoddinott P, Tappin D, Wright C. Breast feeding. BMJ 2008;336:881-887.
16. Ford JL, Stowe RP. Racial-ethnic differences in Epstein-Barr virus antibody titers among U.S. children and adolescents. Ann Epidemiol 2013;23:275-280.
17. Koebnick C, Langer Gould A, Gould MK, et al. Do the sociodemographic characteristics of members of a large, integrated health care system represent the population of interest? Permanente J 2012;16:37-41.
18. Langer-Gould A, Zhang JL, Chung J, Yeung Y, Waubant E, Yao J. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology 2011;77:1143-1148.
19. Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology 2013;80:1734-1739.
20. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
21. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol 2008;28:105-120.
22. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59:499-505.
23. Waubant E, Mowry EM, Krupp L, et al. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult Scler 2013;19:891-895.
24. Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004;74:160-167.
25. Dowd JB, Palermo T, Chyu L, Adam E, McDade TW. Race/ethnic and socioeconomic differences in stress and immune function in the National Longitudinal Study of Adolescent Health. Soc Sci Med 2014;115:49-55.
26. Harrison GJ. Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 7th ed. Philadelphia: Elsevier Saunders; 2014.
27. Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 2011;17:1185-1193.
28. Xiao D, Ye X, Zhang N, et al. A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1∗1501 on risk of multiple sclerosis. Scientific Rep 2015;5:18083.
29. Conradi S, Malzahn U, Paul F, et al. Breastfeeding is associated with lower risk for multiple sclerosis. Mult Scler 2013;19:553-558.
30. Ragnedda G, Leoni S, Parpinel M, et al. Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol 2015;262:1271-1277.
31. Tarrats R, Ordonez G, Rios C, Sotelo J. Varicella, ephemeral breastfeeding and eczema as risk factors for multiple sclerosis in Mexicans. Acta Neurol Scand 2002;105:88-94.
32. Barros FC, Victora CG, Scherpbier R, Gwatkin D. Socio-economic inequities in the health and nutrition of children in low/middle income countries. Rev Saude Publica 2009;44:1-16.